Concepedia

Kristiina Ojamaa

KO

Statistics

Publications

5

Citations

945

H-Index

5

Active since

2013

Affiliations

East Tallinn Central Hospital(Current)

Royal Brisbane and Women's Hospital

Helsinki University Hospital

Royal Marsden Hospital

University Hospitals Seidman Cancer Center

Kristiina Ojamaa is an author at East Tallinn Central Hospital specializing in cancer therapeutics, radiation oncology, and medicine.

ORCID

Top concepts

Publications per year

2013–2024

5

Publications

5

Pembrolizumab for Treatment-Refractory Metastatic Castration-Resistant Prostate Cancer: Multicohort, Open-Label Phase II KEYNOTE-199 Study

Emmanuel S. Antonarakis, Josep M. Piulats, Marine Gross‐Goupil et al. · Journal of Clinical Oncology · 2019 · 679 citations · Full text

Bevacizumab plus chemotherapy continued beyond first progression in patients with metastatic colorectal cancer previously treated with bevacizumab plus chemotherapy: ML18147 study KRAS subgroup findings

Stefan Kubicka, Richard Greil, Thierry André et al. · Annals of Oncology · 2013 · 101 citations · Full text

, , +8

KEYNOTE-199: Pembrolizumab (pembro) for docetaxel-refractory metastatic castration-resistant prostate cancer (mCRPC).

Johann S. de Bono, Jeffrey C. Goh, Kristiina Ojamaa et al. · Journal of Clinical Oncology · 2018 · 97 citations

, , +13

Trends in cervical cancer incidence and survival in Estonia from 1995 to 2014

Kristiina Ojamaa, Kaire Innos, Aleksei Baburin et al. · BMC Cancer · 2018 · 53 citations · Full text

PCM4EU and PRIME-ROSE: Collaboration for implementation of precision cancer medicine in Europe

Kjetil Taskén, Soemeya F. Haj Mohammad, Gro Live Fagereng et al. · Acta Oncologica · 2024 · 15 citations · Full text

1–5 of 5